Tehui Liu

TeHui (Linda) Liu is a Senior Research Scientist at Spark Therapeutics, Inc., since October 2021, with extensive experience in vaccine development for HIV, HCV, and Anthrax using AAV vectors. Previously, TeHui served as a Senior Research Investigator at the University of Pennsylvania and as a Scientist at Limelight Bio. TeHui's career also includes a significant tenure as a Research Scientist at The Children's Hospital of Philadelphia and as a Scientific Director at DMX INC. Earlier experience consists of a postdoctoral fellowship at The Ohio State University, focusing on promoter methylation in CLL patients. TeHui earned a Ph.D. in Molecular Genetics from The Ohio State University and holds a Bachelor of Science in Zoology/Animal Biology from National Taiwan University.